These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 22238444)

  • 41. Performance of Clostridium difficile toxin enzyme immunoassay and nucleic acid amplification tests stratified by patient disease severity.
    Humphries RM; Uslan DZ; Rubin Z
    J Clin Microbiol; 2013 Mar; 51(3):869-73. PubMed ID: 23269736
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of fecal Clostridium difficile load in discrepancies between toxin tests and PCR: is quantitation the next step in C. difficile testing?
    Leslie JL; Cohen SH; Solnick JV; Polage CR
    Eur J Clin Microbiol Infect Dis; 2012 Dec; 31(12):3295-9. PubMed ID: 22814877
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Superiority of the DNA amplification assay for the diagnosis of C. difficile infection: a clinical comparison of fecal tests.
    Barkin JA; Nandi N; Miller N; Grace A; Barkin JS; Sussman DA
    Dig Dis Sci; 2012 Oct; 57(10):2592-9. PubMed ID: 22576711
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of testing approaches for Clostridium difficile infection at a large community hospital.
    Grein JD; Ochner M; Hoang H; Jin A; Morgan MA; Murthy AR
    Clin Microbiol Infect; 2014 Jan; 20(1):65-9. PubMed ID: 23521523
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Toxin Enzyme Immunoassays Detect Clostridioides difficile Infection With Greater Severity and Higher Recurrence Rates.
    Guh AY; Hatfield KM; Winston LG; Martin B; Johnston H; Brousseau G; Farley MM; Wilson L; Perlmutter R; Phipps EC; Dumyati GK; Nelson D; Hatwar T; Kainer MA; Paulick AL; Karlsson M; Gerding DN; McDonald LC
    Clin Infect Dis; 2019 Oct; 69(10):1667-1674. PubMed ID: 30615074
    [TBL] [Abstract][Full Text] [Related]  

  • 46. False Negative Results in Clostridium difficile Testing.
    Murad YM; Perez J; Ybazeta G; Mavin S; Lefebvre S; Weese JS; Rousseau J; Diaz-Mitoma F; Nokhbeh R
    BMC Infect Dis; 2016 Aug; 16(1):430. PubMed ID: 27543102
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Unnecessary repeat Clostridium difficile PCR testing in hospitalized adults with C. difficile-negative diarrhea.
    Nistico JA; Hage JE; Schoch PE; Cunha BA
    Eur J Clin Microbiol Infect Dis; 2013 Jan; 32(1):97-9. PubMed ID: 23010903
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Current status of Clostridium difficile infection epidemiology.
    Lessa FC; Gould CV; McDonald LC
    Clin Infect Dis; 2012 Aug; 55 Suppl 2(Suppl 2):S65-70. PubMed ID: 22752867
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of nine commercially available Clostridium difficile toxin detection assays, a real-time PCR assay for C. difficile tcdB, and a glutamate dehydrogenase detection assay to cytotoxin testing and cytotoxigenic culture methods.
    Eastwood K; Else P; Charlett A; Wilcox M
    J Clin Microbiol; 2009 Oct; 47(10):3211-7. PubMed ID: 19710274
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Optimizing laboratory workflow for the diagnosis of Clostridiodes difficile infection in a medical center in Northern Taiwan.
    Chang FC; Liu CP; Sun FJ; Lin CC
    J Microbiol Immunol Infect; 2021 Apr; 54(2):284-289. PubMed ID: 31624018
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Quantitative fecal lactoferrin in toxin-positive and toxin-negative Clostridium difficile specimens.
    LaSala PR; Ekhmimi T; Hill AK; Farooqi I; Perrotta PL
    J Clin Microbiol; 2013 Jan; 51(1):311-3. PubMed ID: 23135940
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Occurrence of Clostridium difficile ribotype 027 in hospitals of Silesia, Poland.
    Aptekorz M; Szczegielniak A; Wiechuła B; Harmanus C; Kuijper E; Martirosian G
    Anaerobe; 2017 Jun; 45():106-113. PubMed ID: 28216085
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of strain type on detection of toxigenic Clostridium difficile: comparison of molecular diagnostic and enzyme immunoassay approaches.
    Tenover FC; Novak-Weekley S; Woods CW; Peterson LR; Davis T; Schreckenberger P; Fang FC; Dascal A; Gerding DN; Nomura JH; Goering RV; Akerlund T; Weissfeld AS; Baron EJ; Wong E; Marlowe EM; Whitmore J; Persing DH
    J Clin Microbiol; 2010 Oct; 48(10):3719-24. PubMed ID: 20702676
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Predictors of Clostridioides difficile Infection-Related Complications and Treatment Patterns among Nucleic Acid Amplification Test-Positive/Toxin Enzyme Immunoassay-Negative Patients.
    Miller R; Morillas JA; Brizendine KD; Fraser TG
    J Clin Microbiol; 2020 Feb; 58(3):. PubMed ID: 31896665
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Diagnosis of Clostridium difficile: real-time PCR detection of toxin genes in faecal samples is more sensitive compared to toxigenic culture.
    Jensen MB; Olsen KE; Nielsen XC; Hoegh AM; Dessau RB; Atlung T; Engberg J
    Eur J Clin Microbiol Infect Dis; 2015 Apr; 34(4):727-36. PubMed ID: 25421216
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of tcdB real-time PCR in a three-step diagnostic algorithm for detection of toxigenic Clostridium difficile.
    Larson AM; Fung AM; Fang FC
    J Clin Microbiol; 2010 Jan; 48(1):124-30. PubMed ID: 19923482
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The epidemiology of Clostridium difficile infection in children: a population-based study.
    Khanna S; Baddour LM; Huskins WC; Kammer PP; Faubion WA; Zinsmeister AR; Harmsen WS; Pardi DS
    Clin Infect Dis; 2013 May; 56(10):1401-6. PubMed ID: 23408679
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Severe clinical outcome is uncommon in Clostridium difficile infection in children: a retrospective cohort study.
    Schwartz KL; Darwish I; Richardson SE; Mulvey MR; Thampi N
    BMC Pediatr; 2014 Jan; 14():28. PubMed ID: 24485120
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A multicenter evaluation of a sample to answer real-time PCR assay for toxigenic C. difficile in symptomatic subjects.
    Pancholi P; Young S; Widen R; Silbert S; Schmitt B; Dunn R; Drain A; Weissfeld SA
    Diagn Microbiol Infect Dis; 2020 Jan; 96(1):114920. PubMed ID: 31699545
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Three different patterns of positive Clostridium difficile laboratory tests. A comparison of clinical behavior.
    Olmedo M; Alcalá L; Valerio M; Marín M; Onori R; Reigadas E; Muñoz P; Bouza E
    Diagn Microbiol Infect Dis; 2020 Jul; 97(3):115050. PubMed ID: 32482380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.